Genta Incorporated
31Patents
3Active
31Granted
38Portfolio score
Filing activity: Jun 3, 1992 → Mar 11, 2008 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6060456A | Chimeric oligonucleoside compounds | Human Necessities | 101 | Expired |
| US5616337A | Unit dose skin care package | Emerging Cross-Sectional Technologies | 56 | Expired |
| US6020526A | Amide-based cationic lipids | Chemistry; Metallurgy | 52 | Expired |
| US5877220A | Amide-based oligomeric cationic lipids | Chemistry; Metallurgy | 51 | Expired |
| US5958901A | Phosphonic acid-based cationic lipids | Chemistry; Metallurgy | 50 | Expired |
| US5986083A | Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages | Chemistry; Metallurgy | 42 | Expired |
| US6638529B2 | Amide-based cationic lipids | Chemistry; Metallurgy | 39 | Expired |
| US6005094A | Oligonucleotide analogues having improved stability at acid pH | Chemistry; Metallurgy | 35 | Expired |
| US5783683A | Antisense oligonucleotides which reduce expression of the FGFRI gene | Chemistry; Metallurgy | 35 | Expired |
| US5936080A | Compositions and methods for the synthesis of organophosphorus derivatives | Chemistry; Metallurgy | 26 | Expired |
| US6028188A | Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages | Human Necessities | 25 | Expired |
| US6262036A | Method for inhibiting RNA translation using chimeric oligonucleoside compounds | Human Necessities | 24 | Expired |
| US5854410A | Oligonucleoside cleavage compounds and therapies | Chemistry; Metallurgy | 20 | Expired |
| US5606049A | Method of preparing 2'-O-methyl cytidine monomers useful in oligomer synthesis | Chemistry; Metallurgy | 19 | Expired |
| US5789576A | Methylphosphonate dimer synthesis | Chemistry; Metallurgy | 18 | Expired |
| US7119217B2 | Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them | Chemistry; Metallurgy | 15 | Expired |
| US5792615A | Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages | Human Necessities | 12 | Expired |
| US5723599A | Organic polymer reagents for solid phase synthesis of oligonucleotides | Chemistry; Metallurgy | 11 | Expired |
| US5955597A | Chirally enriched synthetic phosphate oligomers | Chemistry; Metallurgy | 11 | Expired |
| US5837856A | Chirally enriched synthetic phosphonate oligomers | Chemistry; Metallurgy | 11 | Expired |
| US5877160A | Compositions and methods of treatment of androgen-associated baldness using antisense oligomers | Chemistry; Metallurgy | 11 | Expired |
| US7060690B2 | Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof | Chemistry; Metallurgy | 11 | Expired |
| US7354952B2 | Pharmaceutical gallium compositions and methods | Emerging Cross-Sectional Technologies | 6 | Active |
| US7456215B2 | Pharmaceutical gallium compositions and methods | Emerging Cross-Sectional Technologies | 4 | Active |
| US5811538A | Process for the purification of oligomers | Performing Operations; Transporting | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.